Synthesis and Biological Evaluation of RGD-Conjugated MEK1/2 Kinase Inhibitors for Integrin-Targeted Cancer Therapy-Reference-Cited by-同舟云学术

Synthesis and Biological Evaluation of RGD-Conjugated MEK1/2 Kinase Inhibitors for Integrin-Targeted Cancer Therapy

Published:2013-11-12 Issue:11 Volume:18 Page:13957-13978
ISSN:1420-3049
Container-title:Molecules
language:en
Short-container-title:Molecules

Author:

Li Xiaoxiao,Hou Jianjun,Wang Chao,Liu Xinjie,He Hongyan,Xu Ping,Yang Zhenjun,Chen Zili,Wu Yun,Zhang Lihe

Publisher

MDPI AG

Subject

Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science

Link

http://www.mdpi.com/1420-3049/18/11/13957/pdf

Reference34 articles.

1. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance;McCubrey;Biochimi. Biophys. Acta,2007

2. The mitogen-activated protein kinase pathway for molecular-targeted cancer treatment;Sebolt-Leopold;Recent Results Canc. Res.,2007

3. MAP kinase pathways

4. Targeting the RAF–MEK–ERK pathway in cancer therapy

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small molecule– and peptide–drug conjugates addressing integrins: A story of targeted cancer treatment;Journal of Peptide Science;2024-02-21

2. MEK inhibitors in cancer treatment: structural insights, regulation, recent advances and future perspectives;RSC Medicinal Chemistry;2023

3. Proteins Drug Targeting and Its Therapeutics;Therapeutic Proteins Against Human Diseases;2022

4. Novel Functionalized Amino Acids as Inhibitors of GABA Transporters with Analgesic Activity;ACS Chemical Neuroscience;2021-08-04

5. Drug Delivery Nanosystems in Glioblastoma Multiforme Treatment: Current State of the Art;Current Neuropharmacology;2021-05-27